Glucose News and Research

RSS

Decaffeinated coffee may cause an increase in harmful LDL cholesterol

Decaffeinated -- not caffeinated -- coffee may cause an increase in harmful LDL cholesterol by increasing a specific type of blood fat linked to the metabolic syndrome, hints a new study presented at the American Heart Association's Scientific Sessions 2005.

16 Nov 2005

Good fitness levels may extend the lives of women with metabolic syndrome

A high level of fitness may extend the lives of women with metabolic syndrome, according to new findings presented today by a cardiologist at Northwestern Memorial Hospital at the annual American Heart Association Scientific Sessions.

15 Nov 2005

Molecular origins of diabetes

An unexpected twist to a discovery reported just two months ago may significantly improve our understanding about the molecular origins of diabetes.

14 Nov 2005

How protein-enriched meals decrease hunger and reduce eating

Researchers have uncovered new evidence to explain the observation that diets rich in protein stunt the appetite, according to a report in the November Cell Metabolism.

13 Nov 2005

Link between diet and epileptic seizures studied

Although the high-fat, calorie-restricted ketogenic diet (KD) has long been used to prevent childhood epileptic seizures that are unresponsive to drugs, physicians have not really understood exactly why the diet works.

13 Nov 2005

One in five Americans has or is at serious risk for developing diabetes

At least one in five Americans has or is at serious risk for developing diabetes, meaning millions are at an increased risk for cardiovascular disease, key health organizations are warning.

8 Nov 2005

2 million American children at risk of diabetes

According to a new study, as many as 2 million children in the U.S. aged 12 to 19 have a prediabetic condition or prediabetes, that is often linked to obesity and physical inactivity.

8 Nov 2005

New discovery helps explain complex neurocircuitry behind body weight control

A study led by a scientific team at Beth Israel Deaconess Medical Center (BIDMC) provides another important step in our understanding of the critical role that the brain's molecular pathways play in the development of obesity and related disorders.

7 Nov 2005

Diabetic black men have lower amounts of atherosclerosis than diabetic white men

In a surprising outcome, investigators at Wake Forest University Baptist Medical Center found that diabetic black men have dramatically lower amounts of atherosclerosis, or hardening of the arteries, than diabetic white men.

3 Nov 2005

Cardiac regeneration using stem cells may heal hearts even years after heart attacks

Left ventricular function and exercise capacity increased, while the area of heart muscle damage shrank, in 18 patients given infusions of their own bone marrow stem cells up to eight years after a heart attack, according to a new study in the Nov. 1, 2005, issue of the Journal of the American College of Cardiology.

27 Oct 2005

Type 2 diabetes and depression can be a fatal mix

Patients whose type 2 diabetes was accompanied by minor or major depression had higher mortality rates, compared to patients with type 2 diabetes alone, over the three-year period of a recent study in Washington state.

27 Oct 2005

Natural blood sugar level lowering compound could lead to new drugs to treat type 2 diabetes

A carbohydrate isolated from the liver lowers blood sugar levels after it is injected into diabetic rats, according to research carried out by a team of experts at the University of Virginia Health System (UVHS).

27 Oct 2005

Rate of weight gain, not the degree of fatness at any one time, which is the main predictor of future problems

Research published today indicates that the risk of heart disease in adulthood is more strongly related to how quickly children gain weight between the ages of two and eleven than their actual body weight at any particular age. Scientists believe this is linked to differences in insulin processing in later life.

27 Oct 2005

New diabetes trial - largest diet and exercise study of its kind

Doctors from the University of Bristol are looking for volunteers who have recently been diagnosed with Type 2 diabetes to take part in the largest diet and exercise study of its kind. The study will be based in local hospitals across the Southwest.

26 Oct 2005

Association of aprotinin with reduced glucose levels during CABG surgery

An anesthesiology research team at Columbia University Medical Center have completed the first human study to show that aprotinin, a protease inhibitor, was associated with lower blood glucose levels during coronary artery bypass graft (CABG) surgery.

25 Oct 2005

Breath-analysis testing may prove to be an effective method for detecting the damaging lung-bacteria growth seen in cystic fibrosis

By using a chemical analysis method developed for air-pollution testing, UCI chemists and pediatricians have found that people with cystic fibrosis exhale higher concentrations of sulfur compounds from their lungs than do people who don't have the disease.

17 Oct 2005

Severe hypoglycemia - complication of gastric bypass surgery

Physicians monitoring patients who have undergone gastric bypass surgery should be on the alert for a new, potentially dangerous hypoglycemia (low blood glucose) complication that, while rare, may require quick treatment, according to a new study

12 Oct 2005

Combining fMRI and PET scanning creates a way to compare different measurements of the brain's function concurrently

Clinical researchers from the University of Pennsylvania Health System (UPHS) are the first to combine fMRI and PET scanning in radiology, creating a way to compare different measurements of the brain's function concurrently. This analysis could lead to better diagnosis and treatment in patients suffering from brain disorders, like Alzheimer's disease.

12 Oct 2005

Glucose test device for diabetics that does not involve pricking the finger

A Syracuse University chemistry professor has patented a device that aims to make painful fingerstick testing of glucose levels a thing of the past for diabetics.

11 Oct 2005

Actos reduces the combined risk of non-fatal heart attacks, strokes in patients with type-2 diabetes

A study published in The Lancet shows that Takeda's Actos (pioglitazone HCl), an oral glucose lowering medication, significantly reduces the combined risk of non-fatal heart attacks, strokes and deaths by an additional 16% on top of standard medication

10 Oct 2005